Chemical Communications

Urgent high quality communications from across the chemical sciences.

Communication

Modification of the duocarmycin pharmacophore enables CYP1A1 targeting for biological activity

*
Corresponding authors
a
Institute of Cancer Therapeutics, University of Bradford, West Yorkshire BD7 1DP, UK
E-mail: L.H.Patterson@Bradford.ac.uk
b
Cancer Research UK Drug-DNA Interactions Research Group, UCL Cancer Institute, London, UK
c
School of Pharmacy, University of East Anglia, Norwich, Norfolk NR4 7TJ, UK
Chem. Commun., 2011,47, 12062-12064

DOI: 10.1039/C1CC15638A
Received 12 Sep 2011, Accepted 04 Oct 2011
First published online 14 Oct 2011
Please wait while Download options loads
 
 

Supplementary Info